Peter Zhang
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Biological Psychiatry top 5%
Papers in ⓘ
- Pharmacology 19
- Treatment of Major Depression 18
-
- RNA Research and Splicing 6
- Co-authors
- William P. Forbes (4 shared papers)Mary Hobart (12 shared papers)Paul D. Thompson (1 shared paper)Aleksandar Skuban (7 shared papers)Robert D. McQuade (6 shared papers)Raymond Sanchez (5 shared papers)Erwei Song (2 shared papers)Yandan Yao (2 shared papers)
- Journals
- Frontiers in Immunology (4 papers)The Journal of Clinical Psychiatry (4 papers)Current Medical Research and Opinion (3 papers)BMC Genomics (3 papers)Molecular Biology and Evolution (3 papers)
- Partner nations
- United StatesCanadaDenmark
In The Last Decade
Peter Zhang
80 papers receiving 3.0k citations
Peers
Comparison fields: 5 of 144
- Cancer Research 574
- Biological Psychiatry 94
- Pharmacology 526
- Psychiatry and Mental health 408
- Internal Medicine 87
Countries citing papers authored by Peter Zhang
This map shows the geographic impact of Peter Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Zhang more than expected).
Fields of papers citing papers by Peter Zhang
This network shows the impact of papers produced by Peter Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Zhang. The network helps show where Peter Zhang may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 82 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 351 | |
| 2 | 2005 | 323 | |
| 3 | Epidermal growth factor receptor-targeted therapy with C225 and cisplatin in patients with head and neck cancer. | 2001 | 250 |
| 4 | 2002 | 199 | |
| 5 | 2013 | 184 | |
| 6 | 2002 | 170 | |
| 7 | 2012 | 163 | |
| 8 | 2015 | 145 | |
| 9 | 2015 | 136 | |
| 10 | 2002 | 73 | |
| 11 | 2010 | 70 | |
| 12 | 2018 | 58 | |
| 13 | 2018 | 53 | |
| 14 | 2006 | 50 | |
| 15 | 2010 | 50 | |
| 16 | 2009 | 50 | |
| 17 | 1998 | 48 | |
| 18 | 1996 | 45 | |
| 19 | 2005 | 32 | |
| 20 | 2001 | 31 |
About Peter Zhang
Peter Zhang is a scholar working on Pharmacology, Molecular Biology, Psychiatry and Mental health, Surgery and Cardiology and Cardiovascular Medicine, having authored 82 papers that have together received 3.1k indexed citations. Recurring topics across this work include Treatment of Major Depression (18 papers), Bipolar Disorder and Treatment (8 papers), Schizophrenia research and treatment (7 papers), RNA Research and Splicing (6 papers), Peripheral Artery Disease Management (6 papers), Venous Thromboembolism Diagnosis and Management (5 papers), Electroconvulsive Therapy Studies (4 papers) and Cerebrovascular and Carotid Artery Diseases (4 papers). The work is most often cited by research in Cancer Research (574 citations), Biological Psychiatry (94 citations), Pharmacology (526 citations), Psychiatry and Mental health (408 citations) and Internal Medicine (87 citations). Peter Zhang has collaborated with scholars based in United States, Canada and Denmark. Frequent co-authors include William P. Forbes, Mary Hobart, Paul D. Thompson, Aleksandar Skuban, Robert D. McQuade, Raymond Sanchez, Erwei Song, Yandan Yao, Michael E. Thase and William R. Hiatt. Their work appears in journals such as Frontiers in Immunology, The Journal of Clinical Psychiatry, Current Medical Research and Opinion, BMC Genomics and Molecular Biology and Evolution.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.